Sun Pharma has agreed to acquire 18.75 per cent shares of Israel-based Tarsius Pharma for a cash consideration of $3 million (over Rs 21 crore).
While this all-under-one roof financial services player draws over 60 per cent of its strength from Bajaj Finance, its insurance arms too offer promise